The chart was showing a clear flag indicating a further move north and breakout from recent trading range. There is plenty more in this from just a charting perspective.
In terms of newsflow, recent rns's suggest that there is more to come in the not too distant.
The market cap is significant. At it's current level, it will appear on the radar of a number of new institutions, and with the growth potential of this stock, will be looked at with great interest.
Remember too, that Phase 1 clinical trials are to commence soon. As trials progress, risk is removed and value ensues.
£60m cap for a company showing every sign of offering a remedy for the fourth largest cancer killer in the world? Looks cheap to me
Sparton stock quotes
Sparton stock charts
Follow this thread
